Nascent Pharma Holdings Inc (NASC)

[sleekscape]

AURORA CEO PREDICTS FDA WILL CHOOSE CBD ISOLATE


7/25/19 — I predicted FDA would choose CBD Isolate as the first CBD formulation to attain federal legality for national sale

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=150123700


7/30/19 — Dr. Gottlieb first insinuated that the FDA would choose CBD Isolate

8/7/19 & 8/9/19 — Dr. Gottlieb for the 2nd and 3rd time “declared” that CBD Isolate is the FDA’s choice

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=150727170


9/12/19 — Aurora Cannabis CEO Terry Booth predicts FDA will choose CBD Isolate during their quarterly conference call

This is a transcript, so “injectables” = ingestibles

Christopher Carey: You mentioned having an idea of how FDA might regulate (CBD) injectables, I wonder if you can elaborate?

Terry Booth: I think what I've said before what keeps me up at night is the supply of cannabis that's no longer an issue with rolling out of the Sky is almost at full production. We - what keeps me up at night now is the FDA decision, it is not the decision that they will make to the negative which way they'll go, with respect to isolates versus broad spectrum.

We are anticipating that to be isolate will be the first step from the FDA as an ingestible mainly because the other 112 or 113 cannabinoids in cannabis and they have not been tested by the World Health Organization. The WHO has come out and said that CBD is safe as ingestible, but they've put brackets around that sentence, this is only for pure CBD.

https://seekingalpha.com/article/4291262-aurora-cannabis-inc-s-acb-ceo-terry-booth-q4-2019-results-earnings-call-transcript


Marco made a very wise choice to go with CBD Isolate for all of CANB’s products

All of the other CBD Oil stocks went with Full Spectrum and Broad Spectrum, formulations which will not be given FDA approval anytime soon:

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=150705614


Sleek